Published in Thromb Haemost on February 19, 2015
Identification of Pathways in Liver Repair Potentially Targeted by Secretory Proteins from Human Mesenchymal Stem Cells. Int J Mol Sci (2016) 0.76
Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation. Stem Cell Res (2016) 0.75
Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation. Glia (2016) 0.75
Mitochondrial Dysfunction Due to Lack of Manganese Superoxide Dismutase Promotes Hepatocarcinogenesis. Antioxid Redox Signal (2015) 0.75
Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci (2016) 0.75
Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget (2016) 0.75
Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost (2004) 1.11
Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C. J Biol Chem (2006) 1.04
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem (2011) 0.96
Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1. Biochem J (2003) 0.91
Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase. Exp Cell Res (2013) 0.91
RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Biochemistry (2010) 0.90
Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain. J Biol Chem (2008) 0.89
Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist. Chem Biol (2013) 0.87
Mutational analysis of plasminogen activator inhibitor-1. Eur J Biochem (2003) 0.87
A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state. Mol Pharmacol (2008) 0.84
Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility. J Mol Biol (2011) 0.83
Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs. Mol Pharmacol (2011) 0.83
Mapping of the epitope of a monoclonal antibody protecting plasminogen activator inhibitor-1 against inactivating agents. Eur J Biochem (2003) 0.82
Protein conformational change delayed by steric hindrance from an N-linked glycan. J Mol Biol (2013) 0.81
Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements. Biochemistry (2009) 0.80
The binding mechanism of a peptidic cyclic serine protease inhibitor. J Mol Biol (2011) 0.78
Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis (2012) 0.78
Detection of active matriptase using a biotinylated chloromethyl ketone peptide. PLoS One (2013) 0.78
Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action. Chembiochem (2013) 0.78
Novel modes of oestrogen receptor agonism and antagonism by hydroxylated and chlorinated biphenyls, revealed by conformation-specific peptide recognition patterns. Mol Cell Endocrinol (2008) 0.76
Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains. J Biol Chem (2012) 0.75
The N-terminal cytoplasmic region of NCBE displays features of an intrinsic disordered structure and represents a novel target for specific drug screening. Front Physiol (2013) 0.75
Resveratrol: beneficial or not? Opposite effects of resveratrol on hypoxia-dependent PAI-1 expression in tumour and primary cells. Thromb Haemost (2015) 0.75
Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved. Thromb Haemost (2017) 0.75
The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha. Thromb Haemost (2010) 0.75
Protein-encapsulated bilirubin: paving the way to a useful probe for singlet oxygen. Photochem Photobiol Sci (2015) 0.75
The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition. J Biol Chem (2017) 0.75